DOI:
10.1055/s-00035024
Thrombosis and Haemostasis
LinksClose Window
References
Perera V, Luettgen JM, Wang Z. , et al.
First-in-human study to assess the safety, pharmacokinetics and pharmacodynamics of BMS-962212, a direct, reversible, small molecule factor XIa inhibitor in non-Japanese and Japanese healthy subjects.
Br J Clin Pharmacol 2018;
84 (05) 876-887
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.